Variability in Hemoglobin Levels and the Factors Associated with Mortality in Hemodialysis Patients: A 78-Month Follow-Up Study
Open Access
- 26 January 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (3), 1078
- https://doi.org/10.3390/ijerph18031078
Abstract
Some studies have described that when the hemoglobin levels of chronic kidney disease (CKD) patients change, especially in those taking erythropoiesis-stimulating agents (ESA), they are associated with unfavorable outcomes such as increased morbidity and mortality, mainly due to cardiovascular events. This prospective cohort study included patients with end-stage renal disease currently undergoing hemodialysis. The initial 6-month clinical evaluation provided data of the variability in hemoglobin, associated blood parameters, and the use of erythropoietin. Subsequently, the patients were followed up for 78 months to evaluate mortality-associated factors. In total, 133 patients completed the 6-month follow-up with a mean age of 47.1 (±13.2) years. The majority were women (51.9%). Six-month hemoglobin levels were as follows: always low (18.0%), intermediate/target (1.5%), always high (0.8%), low-amplitude fluctuation/Hb low (n = 37; 27.8%), low-amplitude fluctuation/Hb high (13.53%), and high-amplitude fluctuation (38.6%), among end-stage renal disease patients. At the end of 78 months, 50 (37.6%) patients died; 70% of deaths were attributed to cardiovascular etiologies. A high variability was observed in hemoglobin levels, which was not associated with mortality. Among all the variables evaluated, age, erythropoietin dose, and transferrin saturation were associated with a higher mortality. Thus, this study suggests that greater attention to erythropoietin doses and transferrin saturation levels may improve the survival of dialysis patients.This publication has 33 references indexed in Scilit:
- An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)Therapeutic Apheresis and Dialysis, 2012
- Hemoglobin Variability and Mortality: Confounding by Disease SeverityAmerican Journal of Kidney Diseases, 2011
- Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID studyNephrology Dialysis Transplantation, 2011
- Age, Race, Diabetes, Blood Pressure, and Mortality among Hemodialysis PatientsJournal of the American Society of Nephrology, 2010
- Hemoglobin Level VariabilityClinical Journal of the American Society of Nephrology, 2008
- Hemoglobin Variability and Mortality in ESRDJournal of the American Society of Nephrology, 2007
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseThe New England Journal of Medicine, 2006
- Elevated Serum Transferrin Saturation and MortalityAnnals of Family Medicine, 2004
- Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobinAmerican Journal of Kidney Diseases, 1999
- Impact of left ventricular hypertrophy on survival in end-stage renal diseaseKidney International, 1989